You are here: Industry Insights > Market News

Market News

InnoCare Announces FDA Approval of Clinical Trial for BCL2 Inhibitor Mesutoclax in AML and MDS PharmaSources
July 14, 2025
July 14, 2025 ，InnoCare Pharma announced that FDA has approved the Investigational New Drug application to conduct the clinical trial of BCL2 inhibitor mesutoclax in combination with azacitidine for the treatment of myeloid malignancies.
InnoCare Announces Approval of Clinical Trial of a Novel ADC ICP-B794 in China PharmaSources
July 04, 2025
InnoCare Pharmaannounced the approval of the Investigational New Drug (IND) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) to conduct the clinical trial of a novel B7-H3 targeted ADC ICP-B794.
Invetech and AiCella Announce Strategic Collaboration to Advance Cell Therapy Innovation PR Newswire
June 27, 2025
Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today announced a strategic collaboration with AiCella.
Infosys and the Mental Health Foundation Australia Launch 'Supportive Mind' App to Boost Mental Health PR Newswire
June 26, 2025
Infosys, a global leader in next-generation digital services and consulting, today announced a strategic collaboration with Mental Health Foundation Australia to further amplify mental health awareness, with thecreation of a mobile app.
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy PR Newswire
June 25, 2025
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy.
LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success PR Newswire
June 25, 2025
LTS LOHMANN Therapie-Systeme AG, announced a strategic collaboration to provide customers with robust, reliable, high-quality and cost-competitive large-scale manufacturing capacities.
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined With DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeosta ACN Newswire
June 23, 2025
Hua Medicine announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA).
CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health ACN Newswire
June 20, 2025
CanSino Biologics Inc. has developed and launched its 13-valent pneumococcal conjugate vaccine, trade name "iPneucia?", optimized for China’s local pneumococcal epidemiology, aiming to provide more precise and safer protection for Chinese children.
The Department of Health - Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi PR Newswire
June 19, 2025
The Department of Health – Abu Dhabi (DoH) and Sanofi signed an MoU at BIO 2025 to expedite development of new global vaccines leveraging Abu Dhabi's health-tech ecosystem.
Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans PRNewswire
June 19, 2025
Immuno Cure and PharmaJet have announced a collaboration to clinically evaluate ICVAX, an innovative HIV therapeutic DNA vaccine, using PharmaJet's needle-free delivery technology.